Company intelligence / Profile preview
Placental Histotherapy Center
Havana, Cubahistoterapia-placentaria.cu ↗
- Ownership
- Private
- Employees
- ~170
- Development stage
- Other
01
Overview
The center's therapies, mainly derived from human placenta extracts, are marketed for vitiligo, psoriasis, and alopecia, claiming high efficacy rates, minimal side effects, and use in over 80 countries. For example, 84% response rates in vitiligo and 78% in psoriasis have been reported, with ongoing research and new programs under clinical evaluation including controlled clinical trials for lead products like Melagenina Plus[1][2][7].
- Therapeutic areas
- HematologyEndocrinologyDermatology
- Modalities
- Biologic
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Heber Biotec (international marketing partner)ENSUFARMA (national distribution partner)
Beyond the preview
Go deeper on Placental Histotherapy Center.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Placental Histotherapy Center.